Brave Asset Management’s Precigen PGEN Stock Holding History

Brave Asset Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,018	Closed	-$56K	–	273
2016 Q3	$56K	Hold	2,018	–	–	0.04%	214
2016 Q2	$49K	Buy	2,018 +504	+33%	+$14.3K	0.03%	220
2016 Q1	$51K	Sell	1,514 -26,587	-95%	-$837K	0.04%	215
2015 Q4	$840K	Sell	28,101 -201	-0.7%	-$6.78K	0.57%	46
2015 Q3	$892K	Hold	28,302	–	–	0.68%	41
2015 Q2	$1.37M	Sell	28,302 -1,152	-4%	-$48.5K	0.96%	30
2015 Q1	$1.28M	Buy	+29,454	New	+$1.06M	0.9%	35

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Brave Asset Management's PGEN Position: Q4 2016 in Review

Brave Asset Management sold out of Precigen (PGEN) in Q4 2016, closing a stake of 2,018 shares — an estimated $56K sold.

Brave Asset Management first reported a position in PGEN in Q1 2015 and held it in 7 quarters. The position peaked at $1.37M in Q2 2015. 171 funds tracked by Wall St. Rank hold PGEN as of Q4 2016.

Brave Asset Management reported no remaining Precigen position as of Q4 2016 after selling out during the quarter.
Brave Asset Management sold 2,018 Precigen shares in Q4 2016, an estimated $56K.
Brave Asset Management first reported a position in Precigen in Q1 2015 and held it in 7 quarters.
Brave Asset Management's Precigen position peaked at $1.37M in Q2 2015.
171 funds tracked by Wall St. Rank held Precigen as of Q4 2016.

Based on Brave Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.